Market Overview

Benzinga's Top Downgrades

Related ABT
Time To Buy Mylan's Clear Path To EPS Upside, JP Morgan Says
Goldman Is Downgrading Abbott Laboratories
Related LLTC
4 Things Worrying Corporate Executives Right Now
Earnings Scheduled For October 13, 2015

Analysts at Raymond James downgraded Abbott Laboratories (NYSE: ABT) from “outperform” to “market perform.” Abbott's shares closed at $69.04 yesterday. Abbott's trailing-twelve-month ROA is 8.67%.

Analysts at Nomura downgraded Linear Technology (NASDAQ: LLTC) from “buy” to “neutral.” Linear Technology's shares closed at $32.22 yesterday. Linear Technology's PEG ratio is 4.54.

Analysts at Stephens downgraded Halliburton Company (NYSE: HAL) from “overweight” to “equal weight.” Halliburton's shares closed at $35.32 yesterday. Halliburton's trailing-twelve-month profit margin is 10.66%.

Goldman Sachs downgraded St. Jude Medical (NYSE: STJ) from “buy” to “neutral.” St. Jude Medical's shares closed at $40.85 yesterday. St. Jude Medical's trailing-twelve-month ROE is 17.25%.

Latest Ratings for ABT

Nov 2015Goldman SachsDowngradesBuyNeutral
Oct 2015BarclaysUpgradesEqual-weightOverweight
Aug 2015Credit SuisseAssumesOutperform

View More Analyst Ratings for ABT
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings


Related Articles (ABT + HAL)

View Comments and Join the Discussion!

Get Benzinga's Newsletters